Irvine, CA, United States of America

Smita S Bhat

This inventor holds 28 USPTO granted patents and 8 published patent applications and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Allergan, Inc.. Active years: 2004-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Smita S Bhat. Retrieved from https://idiyas.com/inventor/smita-s-bhat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 10.7

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
S1P Receptor Modulators
Azetidine Derivatives
Alpha 2 Adrenergic Agents
Therapeutic Compounds
Selective Modulators
Hydropyrido Compounds
Chalcone Oximes
Cytochrome P450 Inhibitors
Retinoid Receptor Antagonists
Serum Glucose Reducing
Anti-Tumor Activity
Phenyl Compounds
28 patents (USPTO):Explore Patents

Title: Inventor Spotlight - Smita S Bhat

Introduction: Smita S Bhat is a talented inventor based in Irvine, CA (US) known for her innovative contributions in various fields.

Latest Patents: Smita S Bhat holds several patents in the areas of technology and healthcare, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Smita S Bhat has had a successful career marked by groundbreaking inventions that have made a significant impact.

Collaborations: Throughout her career, Smita S Bhat has collaborated with leading research institutions, universities, and companies to bring her inventions to life and create real-world applications.

Conclusion: Smita S Bhat's dedication to innovation and her remarkable creativity continue to inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…